Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$1.4 - $25.4 $10,080 - $182,880
-7,200 Reduced 50.7%
7,000 $0
Q3 2022

Oct 25, 2022

BUY
$0.36 - $36.0 $2,664 - $266,400
7,400 Added 108.82%
14,200 $0
Q2 2022

Aug 04, 2022

SELL
$12.3 - $27.3 $9,840 - $21,840
-800 Reduced 10.53%
6,800 $0
Q1 2022

Apr 14, 2022

SELL
$16.6 - $32.3 $929,600 - $1.81 Million
-56,000 Reduced 88.05%
7,600 $0
Q4 2021

Jan 18, 2022

SELL
$29.9 - $61.2 $41,860 - $85,680
-1,400 Reduced 2.15%
63,600 $6,000
Q3 2021

Oct 26, 2021

SELL
$51.4 - $68.2 $5.22 Million - $6.92 Million
-101,500 Reduced 60.96%
65,000 $10,000
Q2 2021

Jul 19, 2021

BUY
$44.1 - $84.0 $3.03 Million - $5.76 Million
68,600 Added 70.07%
166,500 $80,000
Q1 2021

Apr 26, 2021

BUY
$47.0 - $155.7 $4.6 Million - $15.2 Million
97,900 New
97,900 $51,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.